Utama › Kanser Paru-paru Bukan Sel Kecil › Florida › Orlando
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Orlando, FL
44 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Orlando (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- Advent Health, Orlando
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #48, Celebration · 17 mi jauh
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi jauh
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Mengambil pesertaFasa 3
- Clermont Oncology Center, Clermont · 24 mi jauh
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Mengambil pesertaFasa 3
- AdventHealth Cancer Institute, Orlando
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Mengambil pesertaFasa 2
- AdventHealth, Orlando
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Florida Cancer Specialists, Orlando
- Orlando Health Ambulatory Care Center, Orlando
- Orlando Health Cancer Institute, Orlando
- dan 4 lagi
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 2
- Orlando Health Cancer Institute, Orlando
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 2
- AdventHealth Orlando, Orlando
- Orlando Health Cancer Institute, Orlando
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Mengambil pesertaFasa 1/2
- Orlando Health Ambulatory Care Center, Orlando
- Orlando Health Cancer Institute, Orlando
- Orlando Health Orlando Regional Medical Center, Orlando
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Mengambil pesertaFasa 3
- Research Site, Orlando
- Research Site, Clermont · 24 mi jauh
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Mengambil pesertaFasa 2/3
- Clermont Oncology Center, Clermont · 24 mi jauh
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
- Sara Cannon Research Institute Lake Nona, Orlando
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Mengambil pesertaFasa 1
- AdventHealth, Orlando
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Mengambil pesertaFasa 3
- Clinical Study Site, Orlando
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Mengambil pesertaFasa 1
- Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Mengambil pesertaFasa 2/3
- AdventHealth Orlando, Orlando
- Local Institution - 007-896-A, Celebration · 17 mi jauh
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Mengambil pesertaFasa 1/2
- Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona, Orlando
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Orlando Health Cancer Institute, Orlando
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Mengambil pesertaFasa 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Mengambil pesertaFasa 1
- Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Mengambil pesertaFasa 1
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
SMP-3124LP in Adults With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Advent Health, Celebration · 17 mi jauh
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- AdventHealth Celebration, Celebration · 17 mi jauh
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Mengambil pesertaFasa 1/2
- Sarah Cancer Research Institution - Florida Cancer Specialist, Orlando
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Mengambil pesertaFasa 1/2
- Clermont Oncology Center, Clermont · 24 mi jauh
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Mengambil pesertaFasa 1
- Florida Cancer Specialists - Lake Nona, Orlando
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Florida Cancer Specialists, Orlando
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Florida Cancer Specialists, Orlando
A Study of LY4175408 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Study of XB010 in Subjects With Solid Tumors
Mengambil pesertaFasa 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Mengambil pesertaFasa 1/2
- Orlando Health Cancer Institute, Orlando
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Mengambil pesertaFasa 1
- Research Site, Orlando
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Mengambil pesertaFasa 1
- AdventHealth Celebration, Celebration · 17 mi jauh
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Mengambil pesertaFasa 2
- Clermont Oncology Center, Clermont · 24 mi jauh
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Mengambil pesertaFasa 3
- Advent Health, Orlando
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- AdventHealth Cancer Institute, Celebration · 17 mi jauh
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Florida Cancer Specialists-Lake Nona, Orlando
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- Clermont Oncology Center, Clermont · 24 mi jauh
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Florida Cancer Specialists & Research Institute, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Mengambil pesertaFasa 1
- Dren Investigational Site, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · 17 mi jauh
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY121 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH57 kajian
- Washington, DC55 kajian
Kajian lain di Orlando
- Obesiti32 kajian
- Kanser Metastatik29 kajian
- Berat Badan Berlebihan27 kajian
- Penyakit Alzheimer25 kajian
- Diabetes Jenis 225 kajian
- Kanser (semua jenis)24 kajian
- Kanser Payudara23 kajian
- Kanser Ovari22 kajian
- Kolitis Ulseratif22 kajian
- Kanser Paru-paru21 kajian
- Kanser Kolorektal19 kajian
- Gangguan Depresi Major19 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.